| Literature DB >> 34920346 |
Maryam J Syed1, Seher Khan2, Meghan Kataria2, Deepti Zutshi2.
Abstract
Google Trends™ is a popular tool for analyzing healthcare-seeking patterns based on observed changes in the relative search volume (RSV) of the queries made on the Google™ search engine. Google Trends™ was increasingly utilized during the pandemic to assess the impact on mental health, risk communication, the impact of media coverage, and preparedness prediction. The objective of this study was to evaluate the impact of the Coronavirus disease 2019 (COVID-19) pandemic on help-seeking behaviors for seizures and/or epilepsy by assessing the changes in seizure-related online queries in periods before and since the advent of the COVID-19 pandemic on Google Trends™. We compared the RSV volumes in the year prior to and during the COVID-19 pandemic against weekly COVID-19 positive cases for each state and US census regions Search terms were categorized according to seizure symptoms or seizure treatment. Our study showed no significant increase in the RSV for seizure and epilepsy-related searches during the COVID-19 pandemic via Google Trends™. Public health entities and medical systems may use Google Trends ™ as a way to predict national, regional, and local patient needs and drive resources to meet patient demands.Entities:
Keywords: COVID-19; Epilepsy; Google Trends; Seizures
Mesh:
Year: 2021 PMID: 34920346 PMCID: PMC8669502 DOI: 10.1016/j.yebeh.2021.108489
Source DB: PubMed Journal: Epilepsy Behav ISSN: 1525-5050 Impact factor: 2.937
Fig. 1(a and b) RSV (relative search volume) and Cases by category for Northeast, 2019-01-22 to 2020-12-06. (a and b) illustrate the number of RSV spikes for both keyword categories: seizure symptoms (a) and seizure treatment (b) in the Northeast from January through December 2020 period (COVID-19 period), compared to the January to December 2019 (control period). Log scale (dotted line) illustrates the exponentially growing COVID-19 cases.
Fig. 2(a and b) RSV (relative search volume) and Cases by category for Midwest, 2019-01-22 to 2020-12-06. (a and b) illustrate the number of RSV spikes for both keyword categories: seizure symptoms (Fig. 1a) and seizure treatment (Fig. 1b) in the Midwest from January through December 2020 period (COVID-19 period), compared to the January to December 2019 (control period). Log scale (dotted line) illustrates the exponentially growing COVID-19 cases.
Mann–Whitney U test results comparing RSV (Relative Search Volume) series for the control period vs COVID-19 period by category and region.
| Region | Category | Mann Whitney |
|---|---|---|
| Northeast | seizure symptoms | 0.133 |
| seizure treatment | ||
| Midwest | seizure symptoms | 0.027 |
| seizure treatment | 0.430 | |
| West | seizure symptoms | 0.160 |
| seizure treatment | 0.128 | |
| South | seizure symptoms | 0.094 |
| seizure treatment | 0.422 | |
Fig. 3(a and b) Observed and predicted RSV (relative search volume) for both keyword categories: seizure symptoms (a) and seizure treatment (b) in the Northeast from January through December 2020 period (COVID-19 period), compared to the January to December 2019 control period. (a and b) illustrate the application of the control-period based predictive model of the RSV (dotted line), and the observed RSV (blue line) for the “seizure symptoms” (a) and “seizure treatment” (b) categories for the COVID-19 period in the Northeast.